Literature DB >> 28684104

Acid-base disorders in liver disease.

Bernhard Scheiner1, Gregor Lindner2, Thomas Reiberger3, Bruno Schneeweiss4, Michael Trauner3, Christian Zauner3, Georg-Christian Funk5.   

Abstract

Alongside the kidneys and lungs, the liver has been recognised as an important regulator of acid-base homeostasis. While respiratory alkalosis is the most common acid-base disorder in chronic liver disease, various complex metabolic acid-base disorders may occur with liver dysfunction. While the standard variables of acid-base equilibrium, such as pH and overall base excess, often fail to unmask the underlying cause of acid-base disorders, the physical-chemical acid-base model provides a more in-depth pathophysiological assessment for clinical judgement of acid-base disorders, in patients with liver diseases. Patients with stable chronic liver disease have several offsetting acidifying and alkalinising metabolic acid-base disorders. Hypoalbuminaemic alkalosis is counteracted by hyperchloraemic and dilutional acidosis, resulting in a normal overall base excess. When patients with liver cirrhosis become critically ill (e.g., because of sepsis or bleeding), this fragile equilibrium often tilts towards metabolic acidosis, which is attributed to lactic acidosis and acidosis due to a rise in unmeasured anions. Interestingly, even though patients with acute liver failure show significantly elevated lactate levels, often, no overt acid-base disorder can be found because of the offsetting hypoalbuminaemic alkalosis. In conclusion, patients with liver diseases may have multiple co-existing metabolic acid-base abnormalities. Thus, knowledge of the pathophysiological and diagnostic concepts of acid-base disturbances in patients with liver disease is critical for therapeutic decision making.
Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acid-base disorders; Acute liver failure; Cirrhosis; Critically-ill; Liver disease

Mesh:

Year:  2017        PMID: 28684104     DOI: 10.1016/j.jhep.2017.06.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  Metabolic acidosis in critically ill patients with cirrhosis: Epidemiology and short-term mortality risk factors.

Authors:  Feng Gao; Miao-Tong Lin; Xing-Yi Yang; Meng-Xing Cai; Hao Nan; Wei Xie; Zhi-Ming Huang
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

2.  Association of acidosis with coagulopathy and transfusion requirements in liver transplantation.

Authors:  Júlia Ruete de Souza; Ana Paula Yokoyama; Mariana Munari Magnus; Ilka Boin; Elaine Cristina de Ataide; Derli Conceição Munhoz; Fabrício Bíscaro Pereira; Angela Luzo; Fernanda Andrade Orsi
Journal:  J Thromb Thrombolysis       Date:  2021-11-20       Impact factor: 2.300

3.  Lactate and blood ammonia on admission as biomarkers to predict the prognosis of patients with acute mushroom poisoning and liver failure: a retrospective study.

Authors:  Yanguo Gao; Hongqiao Zhang; Hua Zhong; Suosuo Yang; Qiuyan Wang
Journal:  Toxicol Res (Camb)       Date:  2021-07-24       Impact factor: 2.680

4.  Simultaneous Assessment of Intracellular and Extracellular pH Using Hyperpolarized [1-13C]Alanine Ethyl Ester.

Authors:  Jun Chen; Edward P Hackett; Jaspal Singh; Zoltán Kovács; Jae Mo Park
Journal:  Anal Chem       Date:  2020-08-14       Impact factor: 6.986

Review 5.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

6.  Admission Serum Bicarbonate Predicts Adverse Clinical Outcomes in Hospitalized Cirrhotic Patients.

Authors:  Michael Schopis; Anand Kumar; Michael Parides; Adam Tepler; Samuel Sigal
Journal:  Can J Gastroenterol Hepatol       Date:  2021-05-17

7.  Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide.

Authors:  Kelly E Henry; Aisling M Chaney; Veronica L Nagle; Haley C Cropper; Saghar Mozaffari; Gregory Slaybaugh; Keykavous Parang; Oleg A Andreev; Yana K Reshetnyak; Michelle L James; Jason S Lewis
Journal:  J Nucl Med       Date:  2020-01-31       Impact factor: 11.082

8.  Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease.

Authors:  Andreas Drolz; Thomas Horvatits; Kevin Roedl; Karoline Rutter; Richard Brunner; Christian Zauner; Peter Schellongowski; Gottfried Heinz; Georg-Christian Funk; Michael Trauner; Bruno Schneeweiss; Valentin Fuhrmann
Journal:  Ann Intensive Care       Date:  2018-04-19       Impact factor: 6.925

9.  Prevalent metabolic derangement and severe thrombocytopenia in ABO-incompatible liver recipients with pre-transplant plasma exchange.

Authors:  Hye-Mee Kwon; In-Gu Jun; JungBok Lee; Young-Jin Moon; Kyeo-Woon Jung; Hye-Won Jeong; Yong-Seok Park; Jun-Gol Song; Gyu-Sam Hwang
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

10.  Hypophosphatemia in acute liver failure of a broad range of etiologies is associated with phosphaturia without kidney damage or phosphatonin elevation.

Authors:  Christoph Zechner; Beverley Adams-Huet; Blake Gregory; Javier A Neyra; Jody A Rule; Xilong Li; Jorge Rakela; Orson W Moe; William M Lee
Journal:  Transl Res       Date:  2021-07-21       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.